GlassScriptPhysician profile
Karen E Wood
NPI 1649340902
$473.46
in general payments reported to CMS, 2019-2025
14 companies · $84.69 in 2025
The $84.69 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2022: $11.12 · 2023: $147 · 2024: $119 · 2025: $84.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $89.58 | 2019-2024 | Trelegy Ellipta |
| Amgen INC. | $70.97 | 2022-2023 | Repatha, Otezla |
| Lilly USA, LLC | $52.16 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $48.59 | 2019-2025 | |
| Heartflow, INC. | $48.37 | 2023 | Ffrct |
| Kedrion Biopharma, INC. | $21.44 | 2024 | Rhogam Ultra-Filtered Plus, Albuked, Koate |
| Dexcom, INC. | $20.71 | 2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $20.58 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $18.28 | 2024 | Veozah |
| Novo Nordisk INC | $18.10 | 2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $17.46 | 2024 | Airsupra |
| Corcept Therapeutics | $16.99 | 2025 | Korlym |
| Viatris Specialty LLC | $15.70 | 2025 | Yupelri |
| Irhythm Technologies, INC. | $14.53 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.